1058083--2/21/2006--IMS_HEALTH_INC

related topics
{acquisition, growth, future}
{product, market, service}
{system, service, information}
{property, intellectual, protect}
{regulation, government, change}
{regulation, change, law}
{competitive, industry, competition}
{financial, litigation, operation}
{operation, international, foreign}
{personnel, key, retain}
Our data suppliers might restrict our use of or refuse to license data, which could lead to our inability to provide certain products or services. Data protection laws may restrict our activities. Our business is subject to exchange rate fluctuations and our revenue and net income may suffer due to currency translations. Our international operations present risks to our current businesses that could impede growth in the future. We are involved in tax related matters that could have a material effect on us. We are, and may become, involved in litigation that could harm the value of our business. Significant technological changes could render our products and services obsolete. We may not be able to develop the technology necessary for our business, or to do so efficiently. Government imposed price restrictions on pharmaceutical companies could reduce demand for our products and services. Our success will depend on our ability to protect our intellectual property rights. If we are unable to attract, retain and motivate employees, we will not be able to compete effectively and will not be able to expand our business. We may be unsuccessful in identifying acquisition candidates or evaluating the material risks involved in any acquisition. We may be unsuccessful in integrating any acquired operations with our existing business. Consolidation in the industries in which our clients operate may put pressure on the pricing of our products and services, and could increase the cost of acquiring data, leading to decreased earnings. Hardware and software failures, delays in the operation of our computer and communications systems or the failure to implement system enhancements may harm our business. Changes in tax laws or their application may adversely affect our reported results. Our businesses are subject to significant or potential competition that is likely to intensify in the future. The success of our business will largely depend on the performance of the pharmaceutical and healthcare industries.

Full 10-K form ▸

related documents
1058083--2/25/2008--IMS_HEALTH_INC
1058083--2/26/2007--IMS_HEALTH_INC
891103--3/13/2006--IAC/INTERACTIVECORP
891103--2/29/2008--IAC/INTERACTIVECORP
888165--2/28/2007--INTERACTIVE_DATA_CORP/MA/
1138804--1/7/2008--UNICA_CORP
1065860--4/2/2007--LIME_ENERGY_CO.
932112--3/16/2007--APPLIX_INC_/MA/
919012--4/4/2007--AMERICAN_EAGLE_OUTFITTERS_INC
27996--2/16/2007--DELUXE_CORP
36047--3/2/2009--FIRST_AMERICAN_CORP
1166003--3/29/2007--EXPRESS-1_EXPEDITED_SOLUTIONS_INC
901491--2/23/2010--PAPA_JOHNS_INTERNATIONAL_INC
879437--2/26/2010--infoGROUP_Inc.
1200022--3/16/2007--INTEGRATED_ALARM_SERVICES_GROUP_INC
1316360--1/24/2008--IHS_Inc.
1001250--8/28/2007--ESTEE_LAUDER_COMPANIES_INC
1040896--4/2/2007--INTELLI_CHECK_INC
804328--11/2/2006--QUALCOMM_INC/DE
1140414--3/31/2009--SIN_HOLDINGS_INC
1056696--3/15/2006--MANHATTAN_ASSOCIATES_INC
1056696--3/14/2007--MANHATTAN_ASSOCIATES_INC
906465--3/6/2009--QCR_HOLDINGS_INC
764478--5/2/2007--BEST_BUY_CO_INC
6951--12/14/2007--APPLIED_MATERIALS_INC_/DE
891103--2/26/2010--IAC/INTERACTIVECORP
352363--3/4/2009--CLAIBORNE_LIZ_INC
1057758--2/28/2008--TIME_WARNER_TELECOM_INC
721683--2/28/2007--TOTAL_SYSTEM_SERVICES_INC
1166003--3/27/2008--EXPRESS-1_EXPEDITED_SOLUTIONS_INC